New laboratory and clinical aspects of antiviral compounds. Introduction: a virological prescript

A Brief History of Human Challenge Studies (1900-2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D'etre, Ethnography, Selection of Volunteers and Unit Design.

Current topics in microbiology and immunology·2022

The end of the beginning: vaccines for the next 25 years.

Vaccine·2008

Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture.

Archives of virology·2007

Scientific lessons from the first influenza pandemic of the 20th century.

Vaccine·2006

Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection.

Vaccine·2006

Influenza is now a preventable disease.

International journal of antimicrobial agents·2006

Cefoxitin versus cefotaxime as empirical treatment of spontaneous bacterial peritonitis in liver cirrhotic patients: randomized controlled clinical trial.

The Journal of antimicrobial chemotherapy·2026

BV100 (rifabutin IV) drug interaction studies in healthy subjects with index CYP450 3A probes midazolam and itraconazole.

The Journal of antimicrobial chemotherapy·2026

Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanide.

The Journal of antimicrobial chemotherapy·2026

HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.

The Journal of antimicrobial chemotherapy·2026

Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.

The Journal of antimicrobial chemotherapy·2026

Efficacy of new antimicrobial agents against carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacterales in Japan: national genomic surveillance (JARBS 2.0) study.

The Journal of antimicrobial chemotherapy·2026

Synthesis of Tetrahydro-β-Carboline-Based Spirocyclic Peptides via Cascade N-Boc Deprotection and Pictet-Spengler Reaction of Tryptophan: Potent Anti-Inflammatory and Anti-Oxidant Activities.

Drug development research·2026

High-throughput identification of carboxylate-free ligands for the E3 ligase Kelch domain-containing protein 2.

Protein science : a publication of the Protein Society·2026

Advances in N- and S-Heterocycles as c-Jun-N-Terminal Kinase 3 Inhibitors for Alzheimer's Disease Treatment.

Drug development research·2026

A kind of pinky promise: Chain interlocking in the guanidine-II riboswitch observed in atomistic simulations and network analysis.

The Journal of chemical physics·2026

In vitro antiproliferative and anti-inflammatory activities of two phenolic compounds isolated from Pogostemon stellatus.

Natural product research·2026

Potent halt of SARS-CoV-2 replication using clitocine-induced emergent-viral-RNA editing and disruption.

RSC advances·2026

Related Experiment Videos

New laboratory and clinical aspects of antiviral compounds. Introduction: a virological prescript

Related Concept Videos

A Brief History of Human Challenge Studies (1900-2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D'etre, Ethnography, Selection of Volunteers and Unit Design.

The end of the beginning: vaccines for the next 25 years.

Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture.

Scientific lessons from the first influenza pandemic of the 20th century.

Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection.

Influenza is now a preventable disease.

Cefoxitin versus cefotaxime as empirical treatment of spontaneous bacterial peritonitis in liver cirrhotic patients: randomized controlled clinical trial.

BV100 (rifabutin IV) drug interaction studies in healthy subjects with index CYP450 3A probes midazolam and itraconazole.

Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanide.

HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.

Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.

Efficacy of new antimicrobial agents against carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacterales in Japan: national genomic surveillance (JARBS 2.0) study.

Synthesis of Tetrahydro-β-Carboline-Based Spirocyclic Peptides via Cascade N-Boc Deprotection and Pictet-Spengler Reaction of Tryptophan: Potent Anti-Inflammatory and Anti-Oxidant Activities.

High-throughput identification of carboxylate-free ligands for the E3 ligase Kelch domain-containing protein 2.

Advances in N- and S-Heterocycles as c-Jun-N-Terminal Kinase 3 Inhibitors for Alzheimer's Disease Treatment.

A kind of pinky promise: Chain interlocking in the guanidine-II riboswitch observed in atomistic simulations and network analysis.

In vitro antiproliferative and anti-inflammatory activities of two phenolic compounds isolated from Pogostemon stellatus.

Potent halt of SARS-CoV-2 replication using clitocine-induced emergent-viral-RNA editing and disruption.

Related Experiment Videos

New laboratory and clinical aspects of antiviral compounds. Introduction: a virological prescript

Related Concept Videos

Related Articles